Axio Biosolutions Is A Medical Technology Company Based In Ahmedabadindiafounded In 2008The Company Focuses On Developing Biomaterials Based Medical Devicesparticularly For Advanced Wound Care And Bleeding Controlaxio Aims To Improve Patient Outcomes With Its Innovative Products And Aspires To Be A Global Leader In The Biomaterial Medtech Sector Among Its Notable Products Is Axiostata Patented Haemostat That Effectively Stops Moderate To Severe Bleeding In Surgical And Trauma Situationsaxiostat Is Both Us Fda 510 Kcleared And European Ce Approvedanother Key Product Is Maxiocela Next Generation Wound Dressing Designed To Heal Various Types Of Woundsincluding Diabetic Foot Ulcers And Surgical Site Infectionsall Products Are Manufactured In Compliance With Iso 13485 2016 Standards Axio Has A Strong Presence In The Indian Defence Sectorsupplying Products To The Indian Armed Forces And Other Institutionsthe Company Has Raised A Total Of $19 1 Million In Funding And Operates With Around 120 Employeesgenerating A Revenue Of $25 1 Millionaxio Is Expanding Its Manufacturing Capabilities With Plans For A New Facility In Ahmedabad
